Irregular
By Apple Inc.
Irregular Intelligence Room
See. Share. Shape.
Every post on social media is buried the next day. Not here. Signals become memory, and memory becomes intelligence.
Share your experience about Irregular
HealthAratus Reality Window
Irregular
Apple Inc. · Cardiology · HAS 0
No Primary Value Claim has been stated for this Tool.
FDA authorization is regulatory memory. It does not establish real-world effectiveness.
Still unknown
- Apple Inc. has not stated a Primary Value Claim.
- No independently observed deployment yet.
- Independent evidence is sparse.
Governed by HealthAratus. The company may share this Window but cannot edit it. Full Tool page
What HealthAratus sees
The question reality is answering.
Forming
HealthAratus is forming the question Irregular's reality needs answered.
Human reality
What users are seeing.
Gathering
The first real accounts of Irregular are still being gathered.
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Irregular through regulatory records and company records.
- Category
- cardiology
What HealthAratus is still learning
HealthAratus is beginning to understand Irregular. As evidence and experience accumulate, what remains unclear will be stated here.
FDA regulatory history
What regulators have authorized.
1
regulatory decision
2023
first known authorization
2023
latest regulatory activity
Product families: Irregular
- Irregular Rhythm Notification Feature (IRNF)510(k) · K231173 · 2023-07-21
FDA-authorized. No HealthAratus user Signals yet. Authorization is not adoption.
Seen Irregular in practice?
Category ranking
cardiology
87+ tools observed
- 51HeartBeamstableDeveloping
- 52HeartKeystableDeveloping
- 53InfraredxstableDeveloping
- 54IrregularstableDeveloping
- 55Kardia (AliveCor)stableDeveloping
- 56KneevoicestableDeveloping
- 57LoopstableDeveloping
Irregular is ranked number 54 in cardiology by HealthAratus Score). Rankings will change as more intelligence comes in, so follow Irregular to see all changes.
See. Share. Shape.



